Fund Holdings — GREAT POINT PARTNERS LLC

Total Portfolio Value:
$183.97M
Total Bought:
$61.02M
Total Sold:
$53.61M
Net Transaction:
+$7.41M
Notable People:
Ronald Marc Panzier
Securities
▲▼
SharesValue
Q4 2024
▲▼
Q1 2025
▲▼
Change
▲▼
Q4 2024
▲▼
Q1 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Cytokinetics, Incorporated(CYTK)360,000370,000+10,000$16.93M$14.87M8.08%-$2.06M
Kalvista Pharmaceuticals Inc1,787,0031,014,367-772,636$15.14M$11.71M6.36%-$3.43M
Evolus, Inc.(EOLS)895,524944,743+49,219$9.89M$11.37M6.18%+$1.48M
ABIVAX Société AnonymeADS(ABVX)1,648,5231,638,111-10,412$12.07M$10.24M5.57%-$1.83M
Viridian Therapeutics, Inc.(VRDN)750,000750,0000$14.38M$10.11M5.50%-$4.27M
Merus N V158,092237,156+79,064$6.65M$9.98M5.43%+$3.33M
Akebia Therapeutics, Inc.(AKBA)04,973,840+4,973,840$0$9.55M5.19%+$9.55M
Xenon Pharmaceuticals Inc.(XENE)245,272245,2720$9.61M$8.23M4.47%-$1.39M
Ascendis Pharma A/SADR(ASND)050,000+50,000$0$7.79M4.24%+$7.79M
Dynavax Technologies Corp860,000595,879-264,121$10.98M$7.73M4.20%-$3.25M
Ionis Pharmaceuticals, Inc.(IONS)505,007250,000-255,007$17.66M$7.54M4.10%-$10.11M
Amylyx Pharmaceuticals, Inc.(AMLX)01,811,996+1,811,996$0$6.41M3.49%+$6.41M
Immunovant, Inc.(IMVT)0375,000+375,000$0$6.41M3.48%+$6.41M
Unicycive Therapeutics Inc10,980,00010,980,0000$8.72M$6.31M3.43%-$2.41M
Neurogene Inc.(NGNE)442,761470,964+28,203$10.12M$5.51M3.00%-$4.61M
Dianthus Therapeutics, Inc.(DNTH)275,000275,0000$6.00M$4.99M2.71%-$1.01M
Legend Biotech CorporationADS(LEGN)0138,240+138,240$0$4.69M2.55%+$4.69M
Vaxcyte, Inc.(PCVX)0115,517+115,517$0$4.36M2.37%+$4.36M
Autolus Therapeutics plcADS(AUTL)3,009,3922,728,910-280,482$7.07M$4.23M2.30%-$2.84M
Helix Acquisition Corp IiCL A500,000373,833-126,167$5.25M$4.22M2.30%-$1.03M
Zura Bio LimitedCL A(ZURA)3,170,1943,170,1940$7.93M$4.09M2.22%-$3.84M
Beam Therapeutics Inc.(BEAM)0175,562+175,562$0$3.43M1.86%+$3.43M
Arcellx Inc
COMMON STOCK
045,000+45,000$0$2.95M1.60%+$2.95M
Mereo BioPharma Group plcADS(MREO)1,150,0001,275,000+125,000$4.03M$2.87M1.56%-$1.16M
Context Therapeutics Inc.(CNTX)4,683,7114,683,7110$4.92M$2.87M1.56%-$2.05M
Rezolute, Inc.(RZLT)621,894833,042+211,148$3.05M$2.42M1.31%-$631.5K
Centessa Pharmaceuticals PlcADS0149,702+149,702$0$2.15M1.17%+$2.15M
Voyager Therapeutics, Inc.(VYGR)826,751626,275-200,476$4.69M$2.12M1.15%-$2.57M
Promis Neurosciences Inc2,645,1282,645,1280$2.51M$1.84M1.00%-$667.4K
Upstream Bio, Inc.(UPB)300,000300,0000$4.93M$1.84M1.00%-$3.10M
Pliant Therapeutics, Inc.(PLRX)1,055,000850,000-205,000$13.89M$1.15M0.62%-$12.75M
Jasper Therapeutics, Inc.(JSPR)322,3800-322,380$6.89M$0—-$6.89M
Optinose Inc370,2690-370,269$2.47M$0—-$2.47M
Oruka Therapeutics, Inc.(ORKA)228,8030-228,803$4.44M$0—-$4.44M
UroGen Pharma Ltd.(URGN)187,8430-187,843$2.00M$0—-$2.00M
Page 1 of 1
GREAT POINT PARTNERS LLC — 13F Holdings — Q1 2025 | TickerTrail